Abstract
Abstract
Background
Health policy decisions are often informed by estimates of long-term survival based primarily on short-term data. A range of methods are available to include longer-term information, but there has previously been no comprehensive and accessible tool for implementing these.
Results
This paper introduces a novel model and software package for parametric survival modelling of individual-level, right-censored data, optionally combined with summary survival data on one or more time periods. It could be used to estimate long-term survival based on short-term data from a clinical trial, combined with longer-term disease registry or population data, or elicited judgements. All data sources are represented jointly in a Bayesian model. The hazard is modelled as an M-spline function, which can represent potential changes in the hazard trajectory at any time. Through Bayesian estimation, the model automatically adapts to fit the available data, and acknowledges uncertainty where the data are weak. Therefore long-term estimates are only confident if there are strong long-term data, and inferences do not rely on extrapolating parametric functions learned from short-term data. The effects of treatment or other explanatory variables can be estimated through proportional hazards or with a flexible non-proportional hazards model. Some commonly-used mechanisms for survival can also be assumed: cure models, additive hazards models with known background mortality, and models where the effect of a treatment wanes over time. All of these features are provided for the first time in an R package, , in which models can be fitted using standard R survival modelling syntax. This paper explains the model, and demonstrates the use of the package to fit a range of models to common forms of survival data used in health technology assessments.
Conclusions
This paper has provided a tool that makes comprehensive and principled methods for survival extrapolation easily usable.
Publisher
Springer Science and Business Media LLC
Subject
Health Informatics,Epidemiology
Reference46 articles.
1. Latimer NR, Adler AI. Extrapolation beyond the end of trials to estimate long term survival and cost effectiveness. BMJ Med. 2022;1(1).
2. Bullement A, Stevenson MD, Baio G, Shields GE, Latimer NR. A systematic review of methods to incorporate external evidence into trial-based survival extrapolations for health technology assessment. Med Decis Making. 2023. https://doi.org/10.1177/0272989X231168618.
3. Jackson C, Stevens J, Ren S, Latimer N, Bojke L, Manca A, et al. Extrapolating survival from randomized trials using external data: a review of methods. Med Decis Making. 2017;37(4):377–90.
4. Rutherford M, Lambert P, Sweeting M, Pennington R, Crowther MJ, Abrams KR, et al. NICE DSU Technical Support Document 21: Flexible Methods for Survival Analysis. Decision Support Unit, ScHARR, University of Sheffield; 2020.
5. Demiris N, Lunn D, Sharples LD. Survival extrapolation using the poly-Weibull model. Stat Methods Med Res. 2011;24(2):287–301.
Cited by
3 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献